New anti-infective strategies for treatment of tularemia

Frontiers in Cellular and Infection Microbiology

Volumn 4, Issue AUG, 2014, Pages

  Maurin, Max ^a,b,c  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIV GRENOBLE ALPES   (France)

^c CNRS   (France)

Author keywords

Antiinfective agents; Francisella tularensis; Immunomodulators; Tularemia; Virulence

Indexed keywords

ANTIINFECTIVE AGENT; CELECOXIB; CIPROFLOXACIN; GAMMA INTERFERON; GENTAMICIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMIQUIMOD; INTERFERON; LINEZOLID; LIPOQUIN; RESAZURIN; STREPTOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; IMMUNOLOGIC FACTOR;

EDITORIAL; HUMAN; TULAREMIA; ANIMAL; DRUG EFFECTS; FRANCISELLA TULARENSIS; MICROBIOLOGY; PHYSIOLOGY; ZOONOSES;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; FRANCISELLA TULARENSIS; HUMANS; IMMUNOLOGIC FACTORS; TULAREMIA; ZOONOSES;

EID: 84925883798     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2014.00115     Document Type: Editorial

References (10)

1. Abu Kwaik, Y. (2013). Targeting nutrient retrieval by Francisella tularensis. Front. Cell. Infect. Microbiol. 3:64. doi: 10.3389/fcimb.2013.00064
2. Allen, L.-A. H. (2013). Neutrophils: potential therapeutic targets in tularemia. Front. Cell. Infect. Microbiol. 3:109. doi: 10.3389/fcimb.2013.00109
3. Boisset, S., Caspar, Y., Sutera, V., Maurin, M. (2014). New therapeutic approaches for treatment of tularaemia: a review. Front. Cell. Infect. Microbiol. 4:40. doi: 10.3389/fcimb.2014.00040
4. Caspar, Y., Sutera, V., Boisset, S., Denis, J.-N., Maurin, M. (2014). Bis-indolic compounds as potential new therapeutic alternatives for tularaemia. Front. Cell. Infect. Microbiol. 4:24. doi: 10.3389/fcimb.2014.00024
5. Gillette, D. D., Tridandapani, S., Butchar, J. P. (2014). Monocyte/macrophage inflammatory response pathways to combat Francisella infection: possible therapeutic targets? Front. Cell. Infect. Microbiol. 4:18. doi: 10.3389/fcimb.2014.00018
6. Hamblin, K. A., Wong, J. P., Blanchard, J. D., Atkins, H. S. (2014). The potential of liposome-encapsulated ciprofloxacin as a tularemia therapy. Front. Cell. Infect. Microbiol. 4:79. doi: 10.3389/fcimb.2014.00079
7. Jones, B. D., Faron, M., Rasmussen, J. A., Fletcher, J. R. (2014). Uncovering the components of the Francisella tularensis virulence stealth strategy. Front. Cell. Infect. Microbiol. 4:32. doi: 10.3389/fcimb.2014.00032
8. Kingry, L. C., Petersen, J. M. (2014). Comparative review of Francisella tularensis and Francisella novicida. Front. Cell. Infect. Microbiol. 4:35. doi: 10.3389/fcimb.2014.00035
9. Schmitt, D. M., O'Dee, D. M., Cowan, B. N., Birch, J. W.-M., Mazzella, L. K., Nau, G. J., et al. (2013). The use of resazurin as a novel antimicrobial agent against Francisella tularensis. Front. Cell. Infect. Microbiol. 3:93. doi: 10.3389/fcimb.2013.00093
10. Sutera, V., Caspar, Y., Boisset, S., Maurin, M. (2014). Anew dye uptake assay to test the activity of antibiotics against intracellular Francisella tularensis. Front. Cell. Infect. Microbiol. 4:36. doi: 10.3389/fcimb.2014.00036